Previous Article | Next Article ![]()
Infection and Immunity, May 2003, p. 2404-2413, Vol. 71, No. 5
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.5.2404-2413.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Genetics, Harvard Medical School,1 Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114,2 Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 532263
Received 21 November 2002/ Returned for modification 16 January 2003/ Accepted 31 January 2003
| ABSTRACT |
|---|
|
|
|---|
exoU
exoY,
exoT
exoY, and
exoT
exoU double mutants, we determined that individual translocation of either ExoT or ExoU is sufficient to obtain nearly wild-type levels of G. mellonella killing. On the other hand, data obtained with a
exoT
exoU
exoY triple mutant and a
pscD mutant suggested that additional, as-yet-unidentified P. aeruginosa components of type III secretion are involved in virulence in G. mellonella. A high level of correlation between the results obtained in the G. mellonella model and the results of cytopathology assays performed with a mammalian tissue culture system validated the use of G. mellonella for the study of the P. aeruginosa TTSS. | INTRODUCTION |
|---|
|
|
|---|
In gram-negative plant and animal pathogens, a highly conserved feature of pathogenesis is the so-called type III secretion system (TTSS) required for the translocation of effector proteins (virulence factors) directly into the cytosol of target eukaryotic cells (22, 29, 34). In mammals, the main targets of the translocated effector proteins include the host cytoskeleton and innate immune response pathways of macrophages and epithelial cells. For example, in Yersinia spp. and P. aeruginosa, TTSS effector proteins alter the normal actin cytoskeleton and induce apoptosis in infected macrophages, thereby inhibiting phagocytosis (4, 7, 21, 25, 37, 49). Less is known about the mode of action of TTSS effector proteins in plant pathogens. Nevertheless, in all plant pathogens studied to date, the TTSS, which is encoded by the so-called hrp and hrc genes, is absolutely essential for pathogenesis. For Pseudomonas syringae, a relatively large number of putative TTSS effector proteins have been identified (6, 43).
To date, four TTSS effector proteins have been identified for P. aeruginosa, ExoS, ExoT, ExoU, and ExoY (18, 30, 54-56). These P. aeruginosa effector proteins are responsible for disruption of the actin cytoskeleton in host cells (21, 23, 42, 53), inhibition of DNA synthesis (39), interference with cell matrix adherence (40), production of epithelial cell injury (4, 18, 19, 25, 27, 53), inhibition of internalization (10, 23), and induction of apoptosis (25, 32). Interestingly, however, despite the involvement of the TTSS in pathogenesis in a variety of plant and animal pathogens studied to date, no mutations in TTSS-related genes were identified among a total of 8,200 P. aeruginosa strain PA14 random transposon TnphoA insertion mutants screened for decreased virulence in either plants (lettuce) or nematodes (Caenorhabditis elegans) as model hosts (36, 48, 52). These results were particularly surprising because TTSS-related genes represent such a large target for TnphoA insertion events. These results suggested either that TnphoA was not targeting TTSS-related genes in PA14 or that the TTSS was not an important feature of P. aeruginosa pathogenesis in plants and nematodes.
Recently, 1,560 P. aeruginosa PA14 TnphoA mutants (that had previously been screened in C. elegans) were rescreened in the greater wax moth caterpillar Galleria mellonella (S. Miyata et al., unpublished data). P. aeruginosa PA14 kills G. mellonella at a 50% lethal dose (LD50) of approximately 1.0 to 10.0 (depending on experimental conditions) when bacterial cells are injected directly into the G. mellonella body cavity (31). This screen led to the identification of a mutation in the TTSS pscD gene of strain PA14 (S. Miyata et al., unpublished data), suggesting that in contrast to plants and nematodes, G. mellonella and perhaps other insects would be appropriate alternative nonmammalian hosts for identification and study of the components of the P. aeruginosa TTSS. Indeed, a recent publication reporting work that was carried out independently from the experiments reported here showed that the P. aeruginosa TTSS plays a key role in virulence in Drosophila melanogaster (16).
In the present study, we used the G. mellonella-P. aeruginosa model system to examine the TTSS and its role in pathogenesis. We show that strain PA14 does not express ExoS and that although none of the other three known effector proteins (ExoT, ExoU, and ExoY) is essential for virulence, both ExoT and ExoU play significant roles in G. mellonella killing. Moreover, because a
exoT
exoU
exoY triple mutant was less attenuated in virulence than a
pscD mutant, we conclude that additional P. aeruginosa TTSS virulence components remain to be identified. Finally, we found a high level of correlation between the results obtained with G. mellonella and the results of cytopathology assays performed with CHO cells, demonstrating that the G. mellonella model system represents a useful tool for identification and study of the components of type III secretion in P. aeruginosa.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Wild-type pscD replacement in mutant 2B3. A 2.76-kb PCR fragment that contained a wild-type copy of the pscD gene was amplified from strain PA14 with primers that contained SacI and HindIII restriction sites. The PCR-amplified fragment was subcloned into the SacI and HindIII sites of the positive-sucrose-selection suicide vector pEX18Ap (45), generating plasmid pEX18pscD1. Plasmid pEX18pscD1 was used to introduce the wild-type pscD sequence into the homologous region of the 2B3 mutant chromosome by allelic exchange as described previously (15), creating "restored" strain 2B3 (2B3-restored). The replacement was confirmed by Southern blotting and sequencing of a PCR fragment that contained the pscD gene.
Sequencing of the exoS open reading frame and surrounding sequences. For sequence analysis of the PA14 exoS open reading frame, a 1.44-kb PCR product from PA14 was generated with primers exoS1 (5'-TACGGTACCTTCTTCGTGCTCAACGTC-3') and exoS4 (5'-ATCAAGCTTCACGATGGCCTGATTCCAC-3') and sequenced. To corroborate that exoS was not present somewhere else in the genome of strain PA14, Southern blot analysis was performed with a radiolabeled probe generated by random priming (3) from a 0.23-kb fragment that corresponded to part of the PAO1 exoS open reading frame. The probe was used to hybridize EcoRI-digested genomic DNA from strains PA14, PAO1, and PAK.
Sequencing of the exoY open reading frame and surrounding sequences.
For the generation of a PA14
exoY mutant, we sequenced the exoY open reading frame and surrounding sequences because the region upstream of exoY in strain PA14 was different from those in PAO1 and PA388. The PA14 exoY gene was cloned by hybridizing a radiolabeled probe generated from a 1.0-kb PCR fragment that contained most of the PAO1 exoY open reading frame to a PA14 genomic cosmid library in vector pJSR1 (47). A hybridizing clone identified from the genomic library was then subjected to sequence analysis with PAO1- and PA14-specific primers.
Generation of PA14
pscD,
exoT,
exoU,
exoY,
exoT
exoU,
exoT
exoY,
exoU
exoY, and
exoT
exoU
exoY mutants.
The oligonucleotide primers used to generate deletion mutations in the PA14 pscD, exoT, exoU, and exoY genes were designed based on DNA sequences from strain PAO1, except that the exoU downstream primer was based on the PA103 sequence and the exoY and exoU upstream primers were based on the PA14 sequence. The pscD deletion was generated by replacing 2.76 kb of wild-type sequence with a 1.59-kb PCR-amplified fragment that contained a 1.17-kb deletion in the pscD open reading frame. The PCR-amplified fragment containing the deletion was subcloned into the SacI and HindIII sites of pEX18Ap (45), generating plasmid pEX18pscD
1. The resulting construct was used to introduce the deletion of the pscD gene into the wild-type PA14 genome by homologous recombination (15), resulting in the
pscD8 mutant. Similar strategies were used to construct
exoT,
exoU, and
exoY mutants as well as
exoT
exoU,
exoT
exoY,
exoU
exoY, and
exoT
exoU
exoY mutants. For the
exoT,
exoU, and
exoY mutants, we replaced 3.0, 3.6, and 2.8 kb of wild-type sequence with 1.7-, 1.6-, and 1.7-kb PCR-amplified fragments that contained 1.3-, 2.0-, and 1.1-kb deletions, respectively. The PCR-amplified fragments that contained the exoT and exoU deletions were cloned into the KpnI and HindIII sites of pEX18Ap, and the exoY deletion fragment was cloned into the EcoRI and HindIII sites of pEX18Ap, generating plasmids pEX18exoT
4, pEX18exoU
5, and pEX18exoY
4, respectively. The resulting constructs were used to introduce the deletions of the genes into the wild-type PA14 genome, resulting in
exoT1,
exoU3, and
exoY1 mutants. The
exoT
exoU,
exoT
exoY, and
exoU
exoY double mutants were constructed by recombining exoT
4 into
exoU3, exoY
4 into
exoT1, and exoY
4 into
exoU3. The
exoT
exoU
exoY triple mutant was constructed by recombining exoT
4 into the
exoU
exoY double mutant. All of the deletion mutations were confirmed by PCR and/or by Southern blot analysis with radiolabeled probes specific to either upstream or downstream regions. DNA sequence analysis showed that the pscD and exoT deletions were in frame but that the exoU and exoY deletions were out of frame.
Analysis of extracellular proteins. Analysis of extracellular proteins from the different P. aeruginosa strains was performed as described by Hauser et al. (27). A calcium chelator (nitrilotriacetic acid [NTA]; 10 mM) was added to the incubation medium to induce the TTSS. Proteins were recovered from the supernatant by ammonium sulfate precipitation (final concentration, 85% [wt/vol]). Twenty-microliter samples containing precipitated proteins were analyzed on sodium dodecyl sulfate (SDS)-10% polyacrylamide gels stained with Coomassie brilliant blue (3).
Immunoblot analysis. For detection of the PA14 ExoT and ExoU secreted effectors, extracellular proteins were prepared as described above. Proteins were electrotransferred to nitrocellulose for immunoblot analysis. ExoT and ExoU were detected by using rabbit polyclonal ExoT and ExoU antisera specific for the ExoT and ExoU proteins of strain PA103, respectively (kindly provided by J. Engel [26]). Horseradish peroxidase-linked anti-rabbit immunoglobulin G (IgG) (Amersham) diluted 1:2,000 was used as a secondary antibody. The procedures used for Western blotting were described previously (3).
For the detection of PA14 ExoY, cultures grown under type III expression-inducing conditions were concentrated by using an ammonium sulfate solution saturated to 55%. Rabbit antibody specific for ExoY was used at a dilution of 1:20,000. Mouse monoclonal antibody 166, specific for PcrV, was included in the incubation mixture. Peroxidase-labeled secondary antibodies to rabbit IgG and mouse IgG were used at a dilution of 1:7,000, and reactivity was detected by using chemiluminescence.
Invasion assay.
HeLa cells were cultured in MEM
medium (Gibco-BRL) with 10% fetal bovine serum (FBS) (Gibco-BRL). HeLa cells were plated in 12-well tissue culture plates at approximately 105 cells/well and incubated for 20 to 24 h at 37°C with 5% CO2. PA14-derived strains were inoculated into LB broth and incubated overnight at 37°C without shaking as described previously (23). Bacterial cultures were pelleted and resuspended in MEM
medium containing 1% bovine serum albumin (BSA) (Sigma, St. Louis, Mo.) and 20 mM HEPES (Sigma). HeLa cells were washed once with MEM
medium (with 1% BSA and 20 mM HEPES), inoculated in triplicate with 107 bacteria, and incubated for 2 h at 37°C without CO2. Amikacin was added to the infected cells to a final concentration of 400 µg/ml, and the plates were incubated for an additional 2 h at 37°C without CO2. The number of live cells present in the wells at the end of the incubation period was scored by using a hemocytometer after trypan blue staining (Sigma). The removal of antibiotic-containing medium prior to the release of intracellular bacteria was performed as described previously (23). Infected HeLa cells were lysed with phosphate-buffered saline (PBS) (pH 7.4) containing 1% Triton X-100 and incubated for 30 min at room temperature. Serial dilutions of the lysed cells were plated on LB agar. The number of internalized bacteria per well was divided by the number of live cells per well. The ratios were normalized to the ratio obtained with
pscD.
Cytotoxicity assays.
HeLa cells were cultured in MEM
medium with 10% FBS. HeLa cells were transferred to six-well tissue culture plates and incubated for 20 to 24 h to >80% confluence (
5 x 105 cells/well) at 37°C with 5% CO2. Overnight cultures of PA14-derived strains were inoculated onto LB agar plates and incubated overnight at 37°C. Bacterial lawns were washed once with PBS and resuspended in MEM
medium containing 1% BSA and 15 mM HEPES. HeLa cell monolayers were infected in duplicate with 107 bacteria. Following 3 h of incubation at 37°C without CO2, the wells were washed once with PBS. HeLa cells were pelleted at 1,200 rpm (Eppendorf centrifuge) for 5 min, resuspended in 200 µl of PBS, and stained with 0.4% trypan blue in PBS (Sigma). After the cells were dislodged, the fraction of dead cells was scored by using a hemocytometer.
HeLa cell rounding assays.
HeLa cells were cultured in MEM
medium with 10% FBS. HeLa cells were transferred to 24-well tissue culture plates and incubated overnight at 37°C to >80% confluence in the presence of 5% CO2. PA14-derived strains were grown in LB broth overnight at 37°C without shaking. HeLa cells were washed once with MEM
medium (with 1% BSA and 20 mM HEPES), inoculated in triplicate with 106 bacterial cells, and incubated for 4 to 6 h at 37°C without CO2. Rounding was assessed by visual inspection of the wells at magnifications of x100 and x200 by using a Zeiss IM35 microscope.
Bacterial plaque assays. CHO cells were cultured in Ham's F-12 medium (InVitrogen, Carlsbad, Calif.) containing an organic buffer mixture (BufferAll; Sigma) and 10% heat-inactivated newborn calf serum (InVitrogen). CHO cells were seeded in 60-mm tissue culture dishes at a density of 4 x 106 cells/dish and incubated overnight at 37°C in 5% CO2. The bacterial inoculum was prepared by resuspending bacteria grown on agar plates in serum-free Ham's F-12 medium and diluting the suspension to a final concentration of 80 CFU per ml. Cell monolayers were rinsed once with Hanks balanced salt solution without phenol red (InVitrogen), and 0.1 ml of the bacterial inoculum (containing about 8 CFU) was added to each well containing CHO cells. The inoculum was covered with 4 ml of a 1% solution of methylcellulose (Sigma) in Ham's F-12 medium containing BufferAll and 2% heat-inactivated newborn calf serum. The dishes were incubated for 16 to 18 h at 37°C in 5% CO2. Subsequently, methylcellulose was aspirated and the cells were stained with Gram's crystal violet (Becton Dickinson) for at least 5 min. The stain was aspirated, and the dishes were rinsed with water and allowed to dry at room temperature. Plaques, which appeared as circular holes in the monolayers, were counted and measured.
C. elegans and Arabidopsis pathogenicity assays. C. elegans fast killing assays were carried out as described by Mahajan-Miklos et al. (36). Slow killing assays were performed as described by Tan et al. (51). In both cases, worm mortality was scored over time. A worm was considered dead when it failed to respond to touch. Twenty worms were placed on assay plates, which were then incubated at 25°C. E. coli strain OP50 was used as a control for both fast and slow killing assays.
Arabidopsis leaf infiltration assays were carried out as previously described (47) with slight modifications. Five-week-old Arabidopsis ecotype Columbia plants were infiltrated with a 1:100 dilution of log-phase PA14 cultures (OD600, 0.2).
| RESULTS |
|---|
|
|
|---|
In G. mellonella, PA14 mutant 2B3R was significantly attenuated in virulence, with an LD50 of higher than 40,000, compared to an LD50 of 10 for parent strain PA14 (Fig. 1). In contrast, the LD50 of strain 2B3R-restored was not significantly different from the LD50 of wild-type strain PA14 (Fig. 1), confirming that the mutation in the pscD gene is responsible for the avirulent phenotype observed in wax moth caterpillars.
|
pscD) to ensure that the phenotypes observed were linked to the pscD mutation. The deletion was designed to affect the structure of the pscD gene product but not to have a polar effect on the expression of downstream genes, and it was generated as described in Materials and Methods. Despite these precautions, it is nevertheless possible that the mutation could have had an effect on some of the genes downstream of pscD. As shown in Fig. 1, the LD50 of the
pscD in-frame deletion mutant was not significantly different from the LD50 of mutant 2B3R.
The pscD gene is involved in the secretion of TTSS proteins.
The pscD gene in P. aeruginosa is located within a large cluster of genes whose products are thought to be involved in the formation of the type III secretion apparatus, based on their homology to the Ysc injectisome of Yersinia pestis (20, 29). We investigated whether pscD of P. aeruginosa strain PA14 was involved in the secretion of TTSS proteins by analyzing the profiles of secreted proteins by SDS-polyacrylamide gel electrophoresis (PAGE). We took advantage of the fact that the TTSS can be induced in vitro at 37°C in liquid cultures by growing bacteria in media that contain the calcium chelator NTA (27). When the protein profiles from the
pscD mutant were compared to those from wild-type strain PA14, several bands corresponding to secreted proteins were absent from the
pscD mutant (Fig. 2A, lanes 2 and 3). Based on size similarities to proteins from strain PA103 (26, 53), it appears likely that at least some of the proteins absent from supernatants from
pscD mutant cultures corresponded to TTSS protein ExoU (72 kDa), TTSS translocator proteins PopB (40 kDa) and PopD (31.3 kDa), and TTSS extracellular determinant PcrV (32.2 kDa) (Fig. 2A, lanes 2, 3, and 9). As shown in Fig. 2A, lanes 3 and 4, mutant 2B3R showed the same protein profile as the
pscD mutant. On the other hand, the secretion of TTSS proteins was restored to a wild-type profile when the TnphoA insertion was replaced by a wild-type copy of pscD in strain 2B3R-restored (Fig. 2A, lane 5).
|
pscD mutant corresponded to known P. aeruginosa effector proteins (53), we performed immunoblot analysis of supernatants from wild-type strain PA14 and the
pscD mutant by using antibodies specific for the ExoT and ExoU proteins of P. aeruginosa strain PA103 and the ExoY protein of strain PA388. The ExoT and ExoU antisera reacted with secreted proteins in both strain PA14 and strain PA103 (Fig. 2B and C, lanes 1 and 7). In contrast, the ExoT and ExoU antisera did not react with proteins of the expected sizes in the
pscD supernatant (Fig. 2B and C, lanes 2). The ExoY antiserum detected a band in strain PA103/pUC-PexoY but the band was absent from wild-type strain PA14 (Fig. 2D). Although we were unable to detect the ExoY protein by immunoblot analysis, sequence analysis of the exoY region revealed that the exoY open reading frame is present in strain PA14 and is 99% identical to that in strain PA388 (along with 0.6 kb of surrounding sequence). The latter data suggest that the ExoY protein is not expressed in PA14 or is expressed at very low levels. Moreover, sequence analysis allowed us to determine that while the sequences surrounding the exoS open reading frame in strain PAO1 were present in strain PA14, the actual exoS coding sequence was absent from strain PA14 (data not shown). These data were confirmed by Southern blot hybridization with a PAO1 exoS fragment as a probe. The probe specific for the exoS sequence did not hybridize to genomic DNA from PA14 but did hybridize to genomic DNA fragments of the expected sizes from P. aeruginosa strains PAO1 and PAK (data not shown) that encode ExoS (19).
Construction of P. aeruginosa type III secretion effector mutants.
To determine which of the effector proteins secreted through the P. aeruginosa TTSS are involved in G. mellonella killing, we constructed internal deletions in the PA14 exoT, exoU, and exoY genes as described in Materials and Methods. The
exoT
exoU,
exoU
exoY, and
exoT
exoY double mutants and the
exoT
exoU
exoY triple mutant were also constructed as described in Materials and Methods.
To verify that the generated deletion mutations abolished the secretion of the corresponding effector proteins, we analyzed secreted protein profiles by SDS-PAGE and immunoblot analysis after specific induction of type III proteins (see above) and compared them to the profiles of the proteins secreted from strain PA103. Compared to the PA14 control, the
exoU mutant showed one missing band with a molecular weight that corresponded to that of the PA14 ExoU protein (Fig. 2A, lanes 2 and 7). This result was confirmed by immunoblot analysis (Fig. 2C, lanes 1 and 4). Although no clear differences in extracellular protein profiles were observed for the
exoT mutant and the wild type in the Coomassie brilliant blue-stained gel (Fig. 2A, lanes 2 and 6), immunoblot analysis revealed a missing protein of the size expected for ExoT in the
exoT mutant (Fig. 2B, lanes 1 and 3). As stated above, the ExoY antiserum did not detect a band in strain PA14. Profiles of secreted proteins analyzed by SDS-PAGE and immunoblot analysis showed the expected phenotypes for the double mutant (data not shown) and the triple mutant (Fig. 2A, lane 8, and Fig. 2B and C, lanes 6).
The
pscD,
exoT,
exoU, and
exoY mutants were tested by using a mammalian tissue culture system to corroborate that the phenotypes observed for the PA14 deletion mutants corresponded to the phenotypes reported previously for other P. aeruginosa strains (18, 23, 53). We first verified that PA14 ExoT is involved in inhibiting the internalization of P. aeruginosa in HeLa cells. These experiments were performed in a
exoU mutant background because ExoU is cytotoxic and it is difficult to assay bacterial invasion with a cytotoxic strain (23). Figure 3A shows that the ExoT-producing
exoU mutant is internalized in HeLa cells approximately fourfold less efficiently than the
exoT
exoU double mutant, consistent with the proposed role of the ExoT effector protein in inhibiting internalization (23). Moreover, the
exoU
exoY double mutant did not show any significant difference in internalization with respect to the
exoU mutant, indicating that if ExoY is secreted, it does not have an important role in inhibiting internalization (Fig. 3A). We observed that the level of internalization of the
exoT
exoU mutant, which has an intact TTSS apparatus, was reproducibly higher than that of the
pscD mutant (Fig. 3A). A similar finding was reported previously by Garrity-Ryan et al. (23) for strain PA103. These authors attributed the differences in internalization observed between PA103 pscJ::Tn5 and PA103
exoT
exoU to the presence of other type III secretion-dependent factors that promote internalization.
|
pscD and the
exoU strains displayed approximately 13-fold reductions in cytotoxicity compared to wild-type strain PA14 (Fig. 3B), confirming the cytotoxic role of ExoU in strain PA14. On the other hand, the deletion mutations in exoT or exoY did not cause any difference in cytotoxicity compared to wild-type strain PA14 (Fig. 3B).
Previous reports indicated that ExoS, ExoT, and ExoY are involved in cell rounding and disruption of the actin cytoskeleton in CHO and HeLa cells (23, 53). Rounding assays performed with HeLa cells showed that the
exoU
exoY mutant caused dramatic rounding of the cells and confirmed the role of ExoT in disruption of the actin cytoskeleton in strain PA14. On the other hand, little rounding or detachment was observed when HeLa cells were infected with the
pscD or
exoT
exoU
exoY mutant. Moreover, the appearance of the latter cells was similar to that of uninfected cells. Importantly, HeLa cells infected with the
exoT
exoU mutant showed no differences in rounding compared to
pscD or
exoT
exoU
exoY mutant-infected cells, suggesting that if ExoY is secreted by strain PA14, it may not be functional.
Roles of type III effector proteins in G. mellonella killing.
We analyzed the virulence phenotypes of the
exoT,
exoU, and
exoY mutants in the G. mellonella model to determine the roles, if any, of the different effector proteins in G. mellonella killing. Figure 4 shows no statistical differences between the LD50s of the
exoT and
exoY mutants and the wild-type strain, indicating that neither ExoT nor ExoY is essential for G. mellonella killing. On the other hand, the
exoU mutant exhibited a modest but reproducible attenuation in virulence, suggesting that ExoU plays a more significant role in G. mellonella pathogenesis than either ExoT or ExoY. To determine the effects of ExoT, ExoU, and ExoY on wax moth killing when these proteins were translocated individually, we tested
exoU
exoY,
exoT
exoY, and
exoT
exoU double mutants along with a
exoT
exoU
exoY triple mutant. As shown in Fig. 4, the LD50 of the
exoU
exoY mutant was slightly increased in the wax moth killing assay, whereas the
exoT
exoY mutant had the same LD50 as wild-type PA14, indicating that individual translocation of either ExoT or ExoU is sufficient to induce high levels of killing in wax moths. Therefore, simultaneous inactivation of both exoT and exoU was necessary to obtain the high-level attenuated killing phenotype that was observed in the
pscD mutant (Fig. 4). On the other hand, the data obtained with the
exoT
exoU and
exoT
exoU
exoY mutants indicated that ExoY does not play a significant role in killing (Fig. 4).
|
exoT
exoU and
exoT
exoU
exoY mutants, indicating that the ExoY effector protein of PA14 did not have a significant cytopathologic effect on CHO cells (Table 2). Moreover, the
exoT and
exoU mutants formed much larger plaques than the
exoT
exoU double mutant (Table 2), suggesting that individual translocation of either ExoT or ExoU is sufficient to induce high levels of cytopathologic effects, similar to what we observed in the G. mellonella model. Finally, the diameter of plaques formed by the
exoU mutant was slightly different from that of the wild type, whereas the
exoT mutant had the same plaque phenotype as wild-type strain PA14; these results correlated with the results obtained in the wax moth model (Table 2 and Fig. 4).
|
exoT
exoU
exoY triple mutant had a phenotype intermediate between those of the
pscD mutant and wild-type strain PA14 (Table 2). These data suggest the involvement of additional components of type III secretion in PA14 mammalian pathogenesis (Table 2). To determine whether those components could also be detected by using the G. mellonella model system, we designed a time course experiment with PA14 and the
pscD,
exoT,
exoU,
exoY,
exoT
exoU, and
exoT
exoU
exoY mutants. Figure 5 shows that although the
exoT
exoU and
exoT
exoU
exoY mutants had LD50s similar to that of the
pscD mutant at 24 h after injection, when the extent of killing was determined at later times (2 to 4 days), the
exoT
exoU and
exoT
exoU
exoY mutants exhibited approximately 165-fold decreases in their LD50s with respect to the
pscD mutant (Fig. 5). Because the
pscD mutant exhibited a significantly higher LD50 than the
exoT
exoU and
exoT
exoU
exoY mutants at later time points (Fig. 5), these data suggest that additional type III effector proteins also play an important role in wax moth pathogenesis. Moreover, the data suggest that the unidentified type III component(s) relevant for wax moth killing has a predominant effect later in the infection process. Additionally, the
exoU mutant also showed a slight decrease in the LD50 after 24 h (Fig. 5), whereas the
exoT and
exoY mutants showed no statistical differences with respect to the wild type throughout the experiment (data not shown).
|
pscD,
exoT, and
exoU mutants were tested in both fast and slow killing assays. In both C. elegans killing models, all three mutants showed no difference in slow or fast killing with respect to the wild type (Fig. 6A and B), indicating that type III secretion is not required to kill C. elegans.
|
pscD,
exoT, and
exoU mutants infiltrated leaves of the Columbia ecotype of Arabidopsis, and bacterial growth in the infected leaves was monitored over a 6-day period. In the Arabidopsis model, the
pscD,
exoT, and
exoU mutants showed no differences in symptom development or growth in leaves with respect to the wild-type strain (Fig. 6C). | DISCUSSION |
|---|
|
|
|---|
pscD mutant confirmed the importance of the pscD gene in the secretion of TTSS-dependent proteins in strain PA14 (Fig. 2A to C). Some of the proteins present in supernatants from wild-type PA14 cultures, which corresponded to known type III secretion proteins, such as ExoU, PopB, PopD, and PcrV, were not present in supernatants from the
pscD mutant. Moreover, immunoblotting indicated that the ExoT and ExoU effector proteins were not secreted in
pscD mutant supernatants. Four type III effectors have been identified in P. aeruginosa to date: ExoS, ExoT, ExoU, and ExoY (18, 30, 54-56). Sequence analysis showed that although PA14 contains the sequences that surround exoS, the exoS coding sequence is not present in PA14, suggesting that at some point, PA14 may have carried exoS but it was deleted. The latter results agree with reports from Feltman et al. (17) and corroborate the inverse correlation that exists between the presence of the exoS and exoU genes in P. aeruginosa. Analysis of more than 100 P. aeruginosa isolates showed that all isolates but 2 contained either exoS or exoU but not both (17).
Interestingly, antibodies raised against the PA388 ExoY effector protein did not react with any of the proteins secreted in the PA14 supernatant. This result suggests that the ExoY protein may not be expressed in strain PA14 even though the exoY coding sequence is present in the PA14 genome and the sequences corresponding to exoY and 200 bp upstream are 99% identical to those in PA388.
The major goal of the work presented in this report was to determine whether the three known TTSS effector proteins in PA14 (ExoT, ExoU, and ExoY) play a significant role in G. mellonella killing. This goal was accomplished by constructing deletions in the exoT, exoU, and exoY genes, thereby generating
exoT,
exoU, and
exoY mutants;
exoT
exoU,
exoU
exoY, and
exoT
exoY double mutants; and a
exoT
exoU
exoY triple mutant. None of the three single mutants showed the high-level attenuated killing that was observed for the
pscD mutant, indicating that none of the three effectors (ExoT, ExoU, or ExoY) is essential for G. mellonella killing.
On the other hand, the results obtained with the
exoU
exoY and
exoT
exoY double mutants combined with the results obtained with the
exoT and
exoU single mutants indicate that both ExoT and ExoU activities play important roles in pathogenesis and that at least one of these activities is required for a high level of virulence. Importantly, similar results were obtained in the cytopathology assays performed with CHO cells (Table 2). Although the absence of a phenotype for the
exoT mutant in the cytopathology assay would suggest that ExoT does not play a significant role in pathogenesis, the results obtained with the
exoT
exoU double mutant indicated that both ExoT and ExoU are important virulence factors in insect and mammalian pathogenesis. As shown in Fig. 4 and Table 2, the
exoT
exoU double mutant exhibits a much more severe phenotype than either of the single
exoT and
exoU mutants in both G. mellonella and CHO cells. The fact that the single and double TTSS mutants generated in this study exhibit corresponding phenotypes in G. mellonella killing and CHO cytopathology assays validates the use of the G. mellonella model for the identification and study of TTSS components relevant for mammalian pathogenesis.
Interestingly, determining the extent of killing of P. aeruginosa in G. mellonella over the course of several days showed that the
pscD mutant was significantly attenuated with respect to the
exoT
exoU
exoY triple mutant, suggesting that an additional type III effector protein(s) or a type III-mediated mechanism that does not involve any of the effector proteins known in strain PA14 is partly responsible for the
pscD attenuated phenotype. Consistent with these results, recent reports have indicated that an as-yet-unknown type III secretion protein induces apoptosis in macrophages and HeLa cells (25). Moreover, P. aeruginosa cystic fibrosis isolates have been shown to cause ExoU-independent rapid cell death resulting from a pore-forming activity dependent on the intact pcrGVH-popBD operon (11) in macrophages and polymorphonuclear neutrophils (12). Importantly, the data obtained with the
pscD mutant and the
exoT
exoU
exoY triple mutant in G. mellonella also correlated with the data obtained from the cytopathology assay performed with CHO cells (Fig. 5 and Table 2). The
exoT
exoU
exoY triple mutant showed an intermediate phenotype between the
pscD mutant and wild-type PA14. These latter data further validate the use of the G. mellonella model for the study of the TTSS in P. aeruginosa.
Functionally distinct roles have been attributed to the four known effector proteins in P. aeruginosa. ExoT and ExoS are involved in inhibiting internalization and clearance by macrophages and other host cells implicated in defense mechanisms (10, 19, 21, 23). Additionally, ExoS is cytotoxic to eukaryotic cells (21, 40) and has been shown to mediate apoptosis (21, 32). ExoS, ExoT, and ExoY are implicated in disruption of the actin cytoskeleton (21, 23, 42, 53, 56), and ExoU has primarily a cytotoxic effect on host cells (18, 27, 53).
Consistent with previous reports (18, 23), we showed that the PA14 ExoT and ExoU effector proteins are involved in inhibiting the internalization (Fig. 3A) and acute cytotoxicity (Fig. 3B) of HeLa cells, respectively. In addition, cell rounding assays confirmed the role of ExoT in disruption of the actin cytoskeleton (23, 53). In contrast to previous reports, however, no involvement in cell rounding was observed for PA14 ExoY. These results were consistent with the observation that the PA14 ExoY protein could not be detected immunologically, even though an intact exoY gene appears to be present in the PA14 genome.
Even though the TTSS is conserved in various animal and plant pathogens and is involved in virulence in mammals (8), plants (5, 29, 33), and several nonvertebrate hosts, such as G. mellonella (31), D. melanogaster (16), and Dictyostelium discoideum (46), no P. aeruginosa type III secretion mutant had been identified previously from screens of P. aeruginosa mutant libraries in Arabidopsis or C. elegans (36, 48, 52). Consistent with previous results, the data obtained in this study with the
pscD,
exoT, and
exoU mutants suggest that the TTSS does not play a significant role in the virulence of PA14 in either the C. elegans or the Arabidopsis model system. The results obtained clearly indicate that neither of the two modes of C. elegans killing was dependent on an intact type III secretion apparatus (Fig. 6A and B). Because the expression of the TTSS requires cell-to-cell contact (22, 29, 34) and toxin-mediated fast killing does not require live bacteria (51), the TTSS was not necessarily expected to play a role in C. elegans fast killing. However, C. elegans slow killing represents a more suitable system with which to detect an attenuated phenotype, because the mutants are in direct contact with the host. Based on the results obtained in this study, we initially hypothesized that the C. elegans lumen lacks the appropriate environment necessary to induce the expression of the TTSS. However, the identification of a type III secretion gene, invH, during a screen performed with a Salmonella enterica TnphoA-mutagenized library for mutants that exhibited decreased virulence in C. elegans (A. Aballay and F. Ausubel, unpublished data) suggests that the effect of type III secretion proteins in P. aeruginosa may be masked by other virulence factors that play a more predominant role in C. elegans pathogenesis.
PA14 has also been shown to infect and cause disease in Arabidopsis (47). Plant pathogens, such as P. syringae, utilize the TTSS to secrete effector proteins that facilitate disease in susceptible plants and elicit a hypersensitive response in resistant plants (5, 29, 33). While a critical role for type III secretion has been implicated in the full virulence of several bacterial plant pathogens (5, 29, 33), our results show that TTSS mutations had no significant impact on the growth of PA14 in Arabidopsis leaves (Fig. 6C). As is the case in C. elegans, the effect of TTSS proteins may be masked by molecules, such as phospholipase C and exotoxin A, that have been found to be associated with disease symptoms in Arabidopsis leaves (47).
The work described in this report confirmed that G. mellonella is an important nonmammalian model host for study of the TTSS in P. aeruginosa virulence. Our results are consistent with those of a recent study by Fauvarque et al. (16) that showed the importance of the P. aeruginosa TTSS in the induction of the rapid death of D. melanogaster, indicating that insects are appropriate alternative nonmammalian hosts for identification and study of the components of the P. aeruginosa TTSS.
| ACKNOWLEDGMENTS |
|---|
We thank Andrew Diener for helpful suggestions regarding conditions for wax moth experiments.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Aballay, A., and F. M. Ausubel. 2002. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr. Opin. Microbiol. 5:97-101.[CrossRef][Medline] |
| 2. | Apodaca, G., M. Bomsel, R. Lindstedt, J. Engel, D. Frank, K. E. Mostov, and J. Wiener-Kronish. 1995. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect. Immun. 63:1541-1551.[Abstract] |
| 3. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1992. Short protocols in molecular biology, 2nd ed. John Wiley & Sons, Inc., New York, N.Y. |
| 4. | Coburn, J., and D. W. Frank. 1999. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 67:3151-3154. |
| 5. | Cohn, J., G. Sessa, and G. B. Martin. 2001. Innate immunity in plants. Curr. Opin. Immunol. 13:55-62.[CrossRef][Medline] |
| 6. | Collmer, A., J. L. Badel, A. O. Charkowski, W. L. Deng, D. E. Fouts, A. R. Ramos, A. H. Rehm, D. M. Anderson, O. Schneewind, K. van Dijk, and J. R. Alfano. 2000. Pseudomonas syringae Hrp type III secretion system and effector proteins. Proc. Natl. Acad. Sci. USA 97:8770-8777. |
| 7. | Cornelis, G. R., A. Boland, A. P. Boyd, C. Geuijen, M. Iriarte, C. Neyt, M. P. Sory, and I. Stainier. 1998. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1315-1352. |
| 8. | Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735-774.[CrossRef][Medline] |
| 9. | Couillault, C., and J. J. Ewbank. 2002. Diverse bacteria are pathogens of Caenorhabditis elegans. Infect. Immun. 70:4705-4707. |
| 10. | Cowell, B. A., D. Y. Chen, D. W. Frank, A. J. Vallis, and S. M. Fleiszig. 2000. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect. Immun. 68:403-406. |
| 11. | Dacheux, D., J. Goure, J. Chabert, Y. Usson, and I. Attree. 2001. Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol. Microbiol. 40:76-85.[CrossRef][Medline] |
| 12. | Dacheux, D., B. Toussaint, M. Richard, G. Brochier, J. Croize, and I. Attree. 2000. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect. Immun. 68:2916-2924. |
| 13. | Darby, C., C. L. Cosma, J. H. Thomas, and C. Manoil. 1999. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 96:15202-15207. |
| 14. | D'Argenio, D. A., L. A. Gallagher, C. A. Berg, and C. Manoil. 2001. Drosophila as a model host for Pseudomonas aeruginosa infection. J. Bacteriol. 183:1466-1471. |
| 15. | Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317. |
| 16. | Fauvarque, M. O., E. Bergeret, J. Chabert, D. Dacheux, M. Satre, and I. Attree. 2002. Role and activation of type III secretion system genes in Pseudomonas aeruginosa-induced Drosophila killing. Microb. Pathog. 32:287-295.[CrossRef][Medline] |
| 17. | Feltman, H., G. Schulert, S. Khan, M. Jain, L. Peterson, and A. R. Hauser. 2001. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147:2659-2669. |
| 18. | Finck-Barbancon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.[CrossRef][Medline] |
| 19. | Fleiszig, S. M., J. P. Wiener-Kronish, H. Miyazaki, V. Vallas, K. E. Mostov, D. Kanada, T. Sawa, T. S. Yen, and D. W. Frank. 1997. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.[Abstract] |
| 20. | Frank, D. W. 1997. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol. Microbiol. 26:621-629.[CrossRef][Medline] |
| 21. | Frithz-Lindsten, E., Y. Du, R. Rosqvist, and A. Forsberg. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139.[CrossRef][Medline] |
| 22. | Galan, J. E., and A. Collmer. 1999. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284:1322-1328. |
| 23. | Garrity-Ryan, L., B. Kazmierczak, R. Kowal, J. Comolli, A. Hauser, and J. N. Engel. 2000. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 68:7100-7113. |
| 24. | Garsin, D. A., C. D. Sifri, E. Mylonakis, X. Qin, K. V. Singh, B. E. Murray, S. B. Calderwood, and F. M. Ausubel. 2001. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 98:10892-10897. |
| 25. | Hauser, A. R., and J. N. Engel. 1999. Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells. Infect. Immun. 67:5530-5537. |
| 26. | Hauser, A. R., S. Fleiszig, P. J. Kang, K. Mostov, and J. N. Engel. 1998. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect. Immun. 66:1413-1420. |
| 27. | Hauser, A. R., P. J. Kang, and J. N. Engel. 1998. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Microbiol. 27:807-818. |